PhD student, Alemu Tekewe has joined Australian Institute for Biotechnology Nanotechnology (AIBN) from rural Ethiopia to work on cutting-edge vaccine research.

Mr Tekewe works on virus like particle/capsomere platform projects, with the target diseases associated with rotavirus infections. Rotavirus is the most common cause of severe gastroenteritis in infants.

“These projects have been initiated to develop cheap and effective vaccines that can reach the developing countries such as those in Africa, where some infectious diseases are highly prevalent,” Mr Tekewe said.

“We hope to obtain funding for a research assistant and additional students from Ethiopia. Ideally we would like to build a joint AIBN-Ethiopian effort to attack Rotavirus, perhaps through larger-scale projects and even joint laboratories” he said.

The video, which starts by showing Mr Tekewe’s upbringing and the story of his education, is a heartfelt look at the struggles faced by the African continent and is an inspiration for perseverance.